Doctor profile · Federal record
Dr. Nawras Makhsida, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Randolph, NJ
- NPI 1154523959
- Accepts Medicare
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
715 Route 10
Randolph, NJ 078692025
(973) 343-7040
fax (973) 718-4881
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- November 3, 2023
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New Jersey #25MA11801900
- Medicaid
- NJ #0943592
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154523959. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
644
Distinct HCPCS
10
Medicare allowed
$52,819
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 184 | 154 | $125 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 84 | 84 | $174 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 79 | 66 | $3 | |
83036 |
Hemoglobin a1c level | 74 | 66 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 69 | 60 | $34 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 65 | 64 | $90 | |
95249 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 32 | 30 | $62 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 26 | 25 | $138 | |
82947 |
Blood glucose (sugar) level | 16 | 16 | $4 | |
99211 |
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | 13 | $23 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 64. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$58,143
Transactions
159
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 92 | $51,243.38 | |
| Novo Nordisk Inc | 12 | $5,602.39 | |
| Amgen Inc. | 16 | $216.53 | |
| Exeltis, USA Inc. | 1 | $121.77 | |
| AstraZeneca Pharmaceuticals LP | 6 | $103.15 | |
| SANOFI-AVENTIS U.S. LLC | 5 | $93.60 | |
| Abbott Laboratories | 4 | $84.33 | |
| PFIZER INC. | 4 | $72.66 | |
| Amneal Pharmaceuticals LLC | 4 | $65.70 | |
| Medtronic, Inc. | 2 | $51.77 | |
| GlaxoSmithKline, LLC. | 3 | $50.57 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49.90 | |
| Esperion Therapeutics, Inc. | 3 | $45.74 | |
| Antares Pharma, Inc. | 2 | $38.04 | |
| Mannkind Corporation | 2 | $34.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,988
Patients
642
Total drug cost
$1,511,629
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 265 | 106 | $4,096 |
| Soliqua 100-33 (Insulin Glargine/Lixisenatide) | Brand | 254 | 78 | $274,785 |
| Trulicity (Dulaglutide) | Brand | 221 | 58 | $362,538 |
| Jardiance (Empagliflozin) | Brand | 181 | 61 | $214,270 |
| Ozempic (Semaglutide) | Brand | 181 | 48 | $258,268 |
| Atorvastatin Calcium | Generic | 156 | 42 | $1,754 |
| Synjardy Xr (Empagliflozin/Metformin Hcl) | Brand | 131 | 50 | $156,674 |
| Methimazole | Generic | 117 | 44 | $1,930 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 86 | 32 | $6,785 |
| Novolog Flexpen (Insulin Aspart) | Brand | 81 | 18 | $61,387 |
Hospital affiliations
Frequently asked questions
What is Dr. Nawras Makhsida's medical specialty?
Dr. Nawras Makhsida practices Endocrinology, Diabetes & Metabolism Physician in Randolph, NJ.
Where does Dr. Nawras Makhsida practice?
Dr. Nawras Makhsida practices at 715 Route 10, Randolph, NJ 078692025. Office phone: 9733437040.
What is Dr. Nawras Makhsida's NPI?
Dr. Nawras Makhsida's National Provider Identifier (NPI) is 1154523959, issued by NPPES.
Does Dr. Nawras Makhsida accept Medicare assignment?
Yes. Dr. Nawras Makhsida accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nawras Makhsida commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99204); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.